Cardiol Therapeutics's total assets for Q3 2024 were C$17.52M, a decrease of -33.42% from the previous quarter. TSE:CRDL total liabilities were C$7.09M for the fiscal quarter, a -35.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.